Basepoint Wealth’s CVS Health CVS Stock Holding History

Basepoint Wealth’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$325K	Sell	4,523 -98	-2%	-$7.55K	0.19%	75
2025 Q4	$367K	Sell	4,621 -702	-13%	-$55.3K	0.22%	62
2025 Q3	$401K	Sell	5,323 -183	-3%	-$12.5K	0.28%	63
2025 Q2	$380K	Sell	5,506 -162	-3%	-$10.6K	0.29%	65
2025 Q1	$384K	Sell	5,668 -279	-5%	-$16.7K	0.3%	64
2024 Q4	$267K	Sell	5,947 -936	-14%	-$52.5K	0.21%	82
2024 Q3	$433K	Sell	6,883 -49	-0.7%	-$2.86K	0.32%	62
2024 Q2	$409K	Sell	6,932 -165	-2%	-$10.3K	0.32%	64
2024 Q1	$566K	Sell	7,097 -1,093	-13%	-$83.5K	0.43%	59
2023 Q4	$647K	Sell	8,190 -365	-4%	-$26K	0.52%	49
2023 Q3	$597K	Sell	8,555 -658	-7%	-$46.6K	0.49%	50
2023 Q2	$637K	Sell	9,213 -1,169	-11%	-$83.2K	0.53%	48
2023 Q1	$771K	Sell	10,382 -707	-6%	-$59.3K	0.64%	41
2022 Q4	$1.03M	Sell	11,089 -1,303	-11%	-$126K	0.91%	25
2022 Q3	$1.18M	Sell	12,392 -2,906	-19%	-$288K	1.26%	14
2022 Q2	$1.42M	Sell	15,298 -18,461	-55%	-$1.8M	1.48%	14
2022 Q1	$3.42M	Sell	33,759 -13,628	-29%	-$1.43M	3.15%	6
2021 Q4	$4.89M	Buy	+47,387	New	+$4.38M	4.79%	4

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Basepoint Wealth's CVS Position: Q1 2026 in Review

Basepoint Wealth reduced its CVS Health (CVS) stake by 2.1% in Q1 2026, selling an estimated $7.55K and leaving 4,523 shares worth $325K. The position accounts for 0.19% of the portfolio, ranked #75.

Basepoint Wealth first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.89M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Basepoint Wealth held 4,523 shares of CVS Health worth $325K as of Q1 2026.
Basepoint Wealth sold 98 CVS Health shares in Q1 2026, an estimated $7.55K.
CVS Health made up 0.19% of Basepoint Wealth's portfolio in Q1 2026, its #75 holding.
Basepoint Wealth first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
Basepoint Wealth's CVS Health position peaked at $4.89M in Q4 2021.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.